SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Pearson J, Dancis J, Axelrod F, Grover N 1975 The sural nerve in familial dysautonomia. J Neuropathol Exp Neurol 34: 413424.
  • 2
    Maayan C, Bar-On E, Foldes AJ, Gesundheit B, Pollak RD 2002 Bone mineral density and metabolism in familial dysautonomia. Osteoporos Int 13: 429433.
  • 3
    Axelrod F 1995 Familial dysautonomia. In: RoberstonD, BiaggionI (eds.) Disorders of the Autonomic Nervous System, vol. 5. Harwood Academic Publishers, Newark, NJ, USA, pp. 217231.
  • 4
    Maayan C, Becker Y, Gesundheit B, Girgis SI 2001 Calcitonin gene related peptide in familial dysautonomia. Neuropeptides 35: 189195.
  • 5
    Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gibert H, Skinner K, Raumann BE, Basbaum AI, Julius D 1998 The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21: 531543.
  • 6
    Helliwell RJ, McLatchie LM, Clarke M, Winter J, Bevan S, McIntyre P 1998 Capsaicin sensitivity is associated with the expression of the vanilloid (capsaicin) receptor (VR1) mRNA in adult rat sensory ganglia. Neurosci Lett 250: 177180.
  • 7
    Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D 1997 The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389: 816824.
  • 8
    Scadding JW 1980 The permanent anatomical effects of neonatal capsaicin on somatosensory nerves. J Anat 131: 473484.
  • 9
    Nagy JI, Iversen LL, Goedert M, Chapman D, Hunt SP 1983 Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci 3: 399406.
  • 10
    Cervero F, McRitchie HA 1982 Neonatal capsaicin does not affect unmyelinated efferent fibers of the autonomic nervous system: Functional evidence. Brain Res 239: 283288.
  • 11
    Buck SH, Burks TF 1986 The neuropharmacology of capsaicin: Review of some recent observations. Pharmacol Rev 38: 179226.
  • 12
    Virus RM, McManus DQ, Gebhart GF 1982 Capsaicin treatment in adult Wistar-Kyoto and spontaneously hypertensive rats: Effects on substance P contents of peripheral and central nervous system tissues. Eur J Pharmacol 81: 6773.
  • 13
    Helke CJ, DiMicco JA, Jacobowitz DM, Kopin IJ 1981 Effect of capsaicin administration to neonatal rats on the substance P content of discrete CNS regions. Brain Res 222: 428431.
  • 14
    Gamse R, Leeman SE, Holzer P, Lembeck F 1981 Differential effects of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous system of the rat. Naunyn Schmiedebergs Arch Pharmacol 317: 140148.
  • 15
    Cuello AC, Gamse R, Holzer P, Lembeck F 1981 Substance P immunoreactive neurons following neonatal administration of capsaicin. Naunyn Schmiedebergs Arch Pharmacol 315: 185194.
  • 16
    Gamse R, Holzer P, Lembeck F 1980 Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br J Pharmacol 68: 207213.
  • 17
    Hammond DL, Ruda MA 1991 Developmental alterations in nociceptive threshold immunoreactive calcitonin gene-related peptide and substance P, and fluoride-resistant acid phosphatase in neonatally capsaicin-treated rats. J Comp Neurol 312: 436450.
  • 18
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595610.
  • 19
    Ovesen J, Moller-Madsen B, Thomsen JS, Danscher G, Mosekilde L 2001 The positive effects of zinc on skeletal strength in growing rats. Bone 29: 565570.
  • 20
    Schmalbruch H 1986 Fiber composition of the rat sciatic nerve. Anat Rec 215: 7181.
  • 21
    Kalogeris TJ, Monroe F, Tso P 1997 Stimulation of intestinal apolipoprotein A-IV by lipid is independent of capsaicin-sensitive afferent signals. Am J Physiol 273: R981R990.
  • 22
    Li Y, Song D, Zhang Y, Lee SS 2003 Effect of neonatal capsaicin treatment on haemodynamics and renal function in cirrhotic rats. Gut 52: 293299.
  • 23
    Wang DH, Li J, Qiu J 1998 Salt-sensitive hypertension induced by sensory denervation: Introduction of a new model. Hypertension 32: 649653.
  • 24
    Karlsson S, Scheurink AJ, Steffens AB, Ahren B 1994 Involvement of capsaicin-sensitive nerves in regulation of insulin secretion and glucose tolerance in conscious mice. Am J Physiol 267: R1071R1077.
  • 25
    Trudeau F, Milot M 1996 Capsaicin-sensitive nerves and endurance exercise in the rat. Physiol Behav 59: 355359.
  • 26
    Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305317.
  • 27
    Schicho R, Kanai Y, Ishikawa T, Skofitsch G, Donnerer J 1998 Involvement of NGF in the induction of increased noradrenergic innervation of the ureter in neonatally capsaicin-treated rats. J Auton Nerv Syst 73: 4653.
  • 28
    Marfurt CF, Ellis LC, Jones MA 1993 Sensory and sympathetic nerve sprouting in the rat cornea following neonatal administration of capsaicin. Somatosens Mot Res 10: 377398.
  • 29
    Terenghi G, Zhang SQ, Unger WG, Polak JM 1986 Morphological changes of sensory CGRP-immunoreactive and sympathetic nerves in peripheral tissues following chronic denervation. Histochemistry 86: 8995.
  • 30
    Kingery WS, Guo TZ, Davies MF, Limbird L, Maze M 2000 The alpha2 adrenoceptor and the sympathetic postganglionic neuron contribute to the development of neuropathic heat hyperalgesia in mice. Pain 85: 345358.
  • 31
    Kingery WS, Offley SC, Guo TZ, Davies MF, Clark JD, Jacobs CR 2003 A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section. Bone 33: 927936.
  • 32
    Goto T, Tanaka T 2002 Tachykinins and tachykinin receptors in bone. Microsc Res Tech 58: 9197.
  • 33
    Imai S, Matsusue Y 2002 Neuronal regulation of bone metabolism and anabolism: Calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone. Microsc Res Tech 58: 6169.
  • 34
    Bjurholm A 1991 Neuroendocrine peptides in bone. Int Orthop 15: 325329.
  • 35
    Hukkanen M, Konttinen YT, Rees RG, Santavirta S, Terenghi G, Polak JM 1992 Distribution of nerve endings and sensory neuropeptides in rat synovium, meniscus and bone. Int J Tissue React 14: 110.
  • 36
    Hukkanen M, Konttinen YT, Rees RG, Gibson SJ, Santavirta S, Polak JM 1992 Innervation of bone from healthy and arthritic rats by substance P and calcitonin gene related peptide containing sensory fibers. J Rheumatol 19: 12521259.
  • 37
    Goto T, Yamaza T, Kido MA, Tanaka T 1998 Light- and electron-microscopic study of the distribution of axons containing substance P and the localization of neurokinin-1 receptor in bone. Cell Tissue Res 293: 8793.
  • 38
    Irie K, Hara-Irie F, Ozawa H, Yajima T 2002 Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Tech 58: 8590.
  • 39
    Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, Keyser CP, Clohisy DR, Adams DJ, O'Leary P, Mantyh PW 2002 Origins of skeletal pain: Sensory and sympathetic innervation of the mouse femur. Neuroscience 113: 155166.
  • 40
    Imai S, Tokunaga Y, Maeda T, Kikkawa M, Hukuda S 1997 Calcitonin gene-related peptide, substance P, and tyrosine hydroxylase-immunoreactive innervation of rat bone marrows: An immunohistochemical and ultrastructural investigation on possible efferent and afferent mechanisms. J Orthop Res 15: 133140.
  • 41
    Zerari F, Dery O, Fischer J, Frobert Y, Couraud JY, Conrath M 1995 Ultrastructural study of substance P receptors in the dorsal horn of the rat spinal cord using monoclonal anti-complementary peptide antibody. J Chem Neuroanat 9: 6577.
  • 42
    Burgoyne RD, Morgan A 2003 Secretory granule exocytosis. Physiol Rev 83: 581632.
  • 43
    Zupanc GK 1996 Peptidergic transmission: From morphological correlates to functional implications. Micron 27: 3591.
  • 44
    Togari A 2002 Adrenergic regulation of bone metabolism: Possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 58: 7784.
  • 45
    Shih C, Bernard GW 1997 Neurogenic substance P stimulates osteogenesis in vitro. Peptides 18: 323326.
  • 46
    Adamus MA, Dabrowski ZJ 2001 Effect of the neuropeptide substance P on the rat bone marrow-derived osteogenic cells in vitro. J Cell Biochem 81: 499506.
  • 47
    D'Souza SM, MacIntyre I, Girgis SI, Mundy GR 1986 Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro. Endocrinology 119: 5861.
  • 48
    Roos BA, Fischer JA, Pignat W, Alander CB, Raisz LG 1986 Evaluation of the in vivo and in vitro calcium-regulating actions of noncalcitonin peptides produced via calcitonin gene expression. Endocrinology 118: 4651.
  • 49
    Yamamoto I, Kitamura N, Aoki J, Shigeno C, Hino M, Asonuma K, Torizuka K, Fujii N, Otaka A, Yajima H 1986 Human calcitonin gene-related peptide possesses weak inhibitory potency of bone resorption in vitro. Calcif Tissue Int 38: 339341.
  • 50
    Zaidi M, Fuller K, Bevis PJ, Gainesdas RE, Chambers TJ, MacIntyre I 1987 Calcitonin gene-related peptide inhibits osteoclastic bone resorption: A comparative study. Calcif Tissue Int 403: 149154.
  • 51
    Akopian A, Demulder A, Ouriaghli F, Corazza F, Fondu P, Bergmann P 2000 Effects of CGRP on human osteoclast-like cell formation: A possible connection with the bone loss in neurological disorders. Peptides 21: 559564.
  • 52
    Bjurholm A, Kreicbergs A, Schultzberg M, Lerner UH 1992 Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106–01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. J Bone Miner Res 7: 10111019.
  • 53
    Michelangeli VP, Fletcher AE, Allan EH, Nicholson GC, Martin TJ 1989 Effects of calcitonin gene-related peptide on cyclic AMP formation in chicken, rat, and mouse bone cells. J Bone Miner Res 4: 269272.
  • 54
    Tamura T, Miyaura C, Owan I, Suda T 1992 Mechanism of action of amylin in bone. J Cell Physiol 153: 614.
  • 55
    Kawase T, Howard GA, Roos BA, Burns DM 1995 Diverse actions of calcitonin gene-related peptide on intracellular free Ca2+ concentrations in UMR 106 osteoblastic cells. Bone 16 (4 Suppl): 379S384S.
  • 56
    Bernard GW, Shih C 1990 The osteogenic stimulating effect of neuroactive calcitonin gene-related peptide. Peptides 11: 625632.
  • 57
    Shih C, Bernard GW 1997 Calcitonin gene related peptide enhances bone colony development in vitro. Clin Orthop 334: 335344.
  • 58
    Valentijn K, Gutow AP, Troiano N, Gundberg C, Gilligan JP, Vignery A 1997 Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats. Bone 21: 269274.
  • 59
    Hill EL, Turner R, Elde R 1991 Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats. Neuroscience 44: 747755.
  • 60
    Adam C, Llorens A, Baroukh B, Cherruau M, Saffar JL 2000 Effects of capsaicin-induced sensory denervation on osteoclastic resorption in adult rats. Exp Physiol 85: 6266.
  • 61
    Alhashimi N, Frithiof L, Brudvik P, Bakhiet M 2004 CD40-CD40L expression during orthodontic tooth movement in rats. Angle Orthod 74: 100105.
  • 62
    Alhashimi N, Frithiof L, Brudvik P, Bakhiet M 2001 Orthodontic tooth movement and de novo synthesis of proinflammatory cytokines. Am J Orthod Dentofacial Orthop 119: 307312.
  • 63
    Levite M 2000 Nerve-driven immunity. The direct effects of neurotransmitters on T-cell function. Ann NY Acad Sci 917: 307321.
  • 64
    Gendek-Kubiak H, Danowski J, Kmiec BL 2003 A morphological and immunohistochemical investigation of guinea pig skin after the introduction of substance P and VIP. Cell Mol Biol Lett 8: 6367.
  • 65
    Delgado AV, McManus AT, Chambers JP 2003 Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 37: 355361.
  • 66
    Guo CJ, Lai JP, Luo HM, Douglas SD, Ho WZ 2002 Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes. J Neuroimmunol 131: 160167.
  • 67
    Horowitz MC, Lorenzo JA 2001 Local regulators of bone. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, USA, pp. 961978.
  • 68
    Nanes MS 2003 Tumor necrosis factor-alpha: Molecular and cellular mechanisms in skeletal pathology. Gene 321: 115.
  • 69
    Scott C, Perry MJ, Raven PE, Massey EJ, Lisney SJ 2000 Capsaicin-sensitive afferents are involved in signalling transneuronal effects between cutaneous sensory nerves. Neuroscience 95: 535541.
  • 70
    Kingery WS, Castellote JM, Maze M 1999 Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds. Pain 80: 555566.
  • 71
    Kingery WS, Guo TZ, Agashe GS, Davies MF, Clark JD, Maze M 2001 Glucocorticoid inhibition of neuropathic limb edema and cutaneous neurogenic extravasation. Brain Res 913: 140148.
  • 72
    Manolagas SC, Weinstein RS 1999 New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 14: 10611066.
  • 73
    Bergman E, Johnson H, Zhang X, Hokfelt T, Ulfhake B 1996 Neuropeptides and neurotrophin receptor mRNAs in primary sensory neurons of aged rats. J Comp Neurol 375: 303319.
  • 74
    Kiebzak GM, Smith R, Gundberg CC, Howe JC, Sacktor B 1988 Bone status of senescent male rats: Chemical, morphometric, and mechanical analysis. J Bone Miner Res 3: 3745.
  • 75
    Wang L, Banu J, McMahan CA, Kalu DN 2001 Male rodent model of age-related bone loss in men. Bone 29: 141148.